Reneo Pharmaceuticals Ownership 2024 | Who Owns Reneo Pharmaceuticals Now?
Institutional Ownership
44.00%
Insider Ownership
5.19%
Retail Ownership
50.81%
Institutional Holders
30.00
Reneo Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 14.32% | 0.54% | 4,785,494 | - | - | 7,226,096 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 8.97% | 0.46% | 2,996,260 | -740 | -0.02% | 4,524,353 | Jun 30, 2024 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.72% | 0.14% | 2,915,376 | 178,806 | 6.53% | 4,402,218 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 8.08% | 0.39% | 2,698,957 | - | - | 4,156,394 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 8.00% | 2.88% | 2,672,194 | 494,281 | 22.70% | 4,035,013 | Jun 30, 2024 |
| RIVERVEST VENTURE MANAGEMENT LLC | 7.58% | 56.07% | 2,534,220 | - | - | 3,826,672 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 6.73% | 0.53% | 2,250,000 | - | - | 3,397,500 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 2.65% | 0.58% | 886,075 | - | - | 1,337,973 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.64% | - | 882,104 | -88,692 | -9.14% | 1,331,978 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.64% | 0.05% | 547,804 | 547,804 | 100.00% | 846,357 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.63% | 0.06% | 545,000 | 249,625 | 84.51% | 822,950 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.34% | 0.63% | 447,616 | 51,206 | 12.92% | 675,900 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.32% | 0.00% | 442,200 | -151,095 | -25.47% | 667,722 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.22% | 0.33% | 406,209 | 2,161 | 0.53% | 613,376 | Jun 30, 2024 |
| BLACKROCK INC. | 0.88% | - | 293,651 | -700,008 | -70.45% | 443,414 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.60% | - | 201,036 | -131,667 | -39.57% | 303,636 | Jun 30, 2024 |
| MORGAN STANLEY | 0.59% | - | 198,518 | -28,641 | -12.61% | 299,762 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.49% | 0.06% | 165,000 | 165,000 | 100.00% | 249,150 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.43% | - | 144,307 | 105,556 | 272.40% | 217,904 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.39% | 0.00% | 130,743 | -3,289 | -2.45% | 213,111 | Jun 30, 2024 |
Reneo Pharmaceuticals's largest institutional shareholder is NEA MANAGEMENT COMPANY, LLC, holding 14.32% of the company's total share outstanding, currently valued at $7.23M. The top 10 institutional shareholders own together 69.32% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RIVERVEST VENTURE MANAGEMENT LLC | 7.58% | 56.07% | 2,534,220 | - | - | 3,826,672 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 8.00% | 2.88% | 2,672,194 | 494,281 | 22.70% | 4,035,013 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.34% | 0.63% | 447,616 | 51,206 | 12.92% | 675,900 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 2.65% | 0.58% | 886,075 | - | - | 1,337,973 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 14.32% | 0.54% | 4,785,494 | - | - | 7,226,096 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 6.73% | 0.53% | 2,250,000 | - | - | 3,397,500 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 8.97% | 0.46% | 2,996,260 | -740 | -0.02% | 4,524,353 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 8.08% | 0.39% | 2,698,957 | - | - | 4,156,394 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.22% | 0.33% | 406,209 | 2,161 | 0.53% | 613,376 | Jun 30, 2024 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.72% | 0.14% | 2,915,376 | 178,806 | 6.53% | 4,402,218 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.63% | 0.06% | 545,000 | 249,625 | 84.51% | 822,950 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.49% | 0.06% | 165,000 | 165,000 | 100.00% | 249,150 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.64% | 0.05% | 547,804 | 547,804 | 100.00% | 846,357 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.22% | 0.02% | 73,770 | - | - | 111,393 | Jun 30, 2024 |
| JBF CAPITAL, INC. | 0.24% | 0.02% | 80,000 | - | - | 120,800 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.05% | 0.01% | 18,027 | 18,027 | 100.00% | 27,221 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.17% | 0.00% | 55,676 | 55,676 | 100.00% | 84,071 | Jun 30, 2024 |
| CSS LLC/IL | 0.06% | 0.00% | 20,288 | - | - | 30,635 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.32% | 0.00% | 442,200 | -151,095 | -25.47% | 667,722 | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 0.01% | 0.00% | 3,927 | -2,461 | -38.53% | 5,930 | Jun 30, 2024 |
The largest Reneo Pharmaceuticals shareholder by % of total assets is RIVERVEST VENTURE MANAGEMENT LLC. The company owns 2.53M shares of Reneo Pharmaceuticals (RPHM), representing 56.07% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.64% | 0.05% | 547,804 | 547,804 | 100.00% | 846,357 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 8.00% | 2.88% | 2,672,194 | 494,281 | 22.70% | 4,035,013 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.63% | 0.06% | 545,000 | 249,625 | 84.51% | 822,950 | Jun 30, 2024 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.72% | 0.14% | 2,915,376 | 178,806 | 6.53% | 4,402,218 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.49% | 0.06% | 165,000 | 165,000 | 100.00% | 249,150 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.33% | 0.00% | 109,987 | 109,987 | 100.00% | 166,080 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.43% | - | 144,307 | 105,556 | 272.40% | 217,904 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.17% | 0.00% | 55,676 | 55,676 | 100.00% | 84,071 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.16% | 0.00% | 55,043 | 55,043 | 100.00% | 83,115 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 1.34% | 0.63% | 447,616 | 51,206 | 12.92% | 675,900 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.07% | 0.00% | 24,000 | 24,000 | 100.00% | 36,240 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | - | 19,487 | 19,487 | 100.00% | 29,425 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.05% | 0.01% | 18,027 | 18,027 | 100.00% | 27,221 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.04% | - | 14,218 | 14,218 | 100.00% | 21,469 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.03% | 0.00% | 11,675 | 11,675 | 100.00% | 17,629 | Jun 30, 2024 |
| FMR LLC | 0.04% | - | 12,622 | 11,017 | 686.42% | 19,059 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.03% | - | 10,400 | 10,400 | 100.00% | 15,705 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | - | 6,508 | 6,508 | 100.00% | 9,827 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.35% | - | 117,860 | 5,717 | 5.10% | 177,968,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 14,939 | 5,461 | 57.62% | 22,558 | Jun 30, 2024 |
As of Jun 30 2024, Reneo Pharmaceuticals's largest institutional buyer is NANTAHALA CAPITAL MANAGEMENT, LLC. The company purchased 547.80K stocks of RPHM, valued at $846.36K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -751,730 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 0.88% | - | 293,651 | -700,008 | -70.45% | 443,414 | Jun 30, 2024 |
| STATE STREET CORP | 0.21% | - | 71,636 | -175,794 | -71.05% | 108,170,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.32% | 0.00% | 442,200 | -151,095 | -25.47% | 667,722 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.60% | - | 201,036 | -131,667 | -39.57% | 303,636 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.64% | - | 882,104 | -88,692 | -9.14% | 1,331,978 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -88,020 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,503 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -34,227 | -100.00% | - | Jun 30, 2024 |
| FIFTH LANE CAPITAL, LP | - | - | - | -32,635 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.59% | - | 198,518 | -28,641 | -12.61% | 299,762 | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -23,496 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.33% | 0.00% | 111,856 | -18,733 | -14.35% | 168,903 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -18,226 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -18,041 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -17,223 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 983 | -9,989 | -91.04% | 1,484 | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -8,158 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | - | 7,922 | -7,122 | -47.34% | 11,963 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -6,330 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Reneo Pharmaceuticals's biggest institutional seller is ROCK SPRINGS CAPITAL MANAGEMENT LP. The company sold -0.75M shares of RPHM, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.64% | 0.05% | 547,804 | 547,804 | 100.00% | 846,357 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.49% | 0.06% | 165,000 | 165,000 | 100.00% | 249,150 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.17% | 0.00% | 55,676 | 55,676 | 100.00% | 84,071 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.16% | 0.00% | 55,043 | 55,043 | 100.00% | 83,115 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.07% | 0.00% | 24,000 | 24,000 | 100.00% | 36,240 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | - | 19,487 | 19,487 | 100.00% | 29,425 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.05% | 0.01% | 18,027 | 18,027 | 100.00% | 27,221 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.03% | 0.00% | 11,675 | 11,675 | 100.00% | 17,629 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.03% | - | 10,400 | 10,400 | 100.00% | 15,705 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | - | 6,508 | 6,508 | 100.00% | 9,827 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 5,021 | 5,021 | 100.00% | 7,582 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | - | 998 | 998 | 100.00% | 1,607 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 647 | 647 | 100.00% | 977 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 171 | 171 | 100.00% | 259 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 40 | 40 | 100.00% | 60 | Jun 30, 2024 |
Reneo Pharmaceuticals's largest new institutional shareholder by number of shares is NANTAHALA CAPITAL MANAGEMENT, LLC, purchased 547.80K shares, valued at $846.36K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -751,730 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -88,020 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,503 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -34,227 | -100.00% | - | Jun 30, 2024 |
| FIFTH LANE CAPITAL, LP | - | - | - | -32,635 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -23,496 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -18,226 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -18,041 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -17,223 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -8,158 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -6,330 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -1,458 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -1,418 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | - | - | - | -821 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -799 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -744 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -637 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -327 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -41 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Reneo Pharmaceuticals's largest sold out institutional shareholder by shares sold is ROCK SPRINGS CAPITAL MANAGEMENT LP, sold -0.75M shares, valued at -, as of undefined.
Reneo Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FRANKLIN STRATEGIC SERIES | 0.06% | 473,833 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.04% | 91,380 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 14,000 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 3,329 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 22,003 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 29,756 | 29,756 | - | Mar 28, 2024 |
| Federated Hermes Equity Funds | 0.00% | 60,000 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,506 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 874,654 | -278,541 | -24.15% | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 24,270 | 24,270 | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,810 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,673 | - | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 37,503 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 181,247 | -712 | -0.39% | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 2,078,142 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,013 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 799 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,461 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 820 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 18,226 | 7,155 | 64.63% | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 446 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,400 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 4,000 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 753,516 | 11,889 | 1.60% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 759 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 30,807 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 58,502 | 6,371 | 12.22% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 26,396 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 89 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 4,388 | 2,712 | 161.81% | Feb 29, 2024 |
| VALIC Co I | 0.00% | 4,980 | -20 | -0.40% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,263 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 400 | - | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 5,692 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,567 | 413 | 19.17% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 44 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 1,472 | -4,690 | -76.11% | Mar 28, 2024 |
| ProFunds | 0.00% | 100 | -8 | -7.41% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 848 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 50 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 525 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,017 | 101 | 11.03% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 6 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 10,600 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,470 | -6 | -0.41% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 11,909 | -1,617 | -11.95% | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 901 | -438,000 | -99.79% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 48 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 7,631 | 497 | 6.97% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 1,923 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 3,535 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 3,702 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 807 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 59 | -4,210 | -98.62% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,118 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,355 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 651 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,421 | 319 | 28.95% | Jan 31, 2024 |
Reneo Pharmaceuticals's largest mutual fund holder by % of total assets is "FRANKLIN STRATEGIC SERIES", owning 473.83K shares, compromising 0.06% of its total assets.
Reneo Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 30 | -54.55% |
| 31 Mar, 24 | 66 | -15.38% |
| 31 Dec, 23 | 78 | 32.20% |
| 30 Sep, 23 | 59 | 15.69% |
| 30 Jun, 23 | 51 | 50.00% |
| 31 Mar, 23 | 34 | 9.68% |
| 31 Dec, 22 | 31 | - |
| 30 Sep, 22 | 31 | 6.90% |
| 30 Jun, 22 | 29 | -27.50% |
| 31 Mar, 22 | 40 | 2.56% |
| 31 Dec, 21 | 39 | 2.63% |
| 30 Sep, 21 | 38 | 2.70% |
| 30 Jun, 21 | 37 | - |
As of 30 Jun 24, 30 institutions are holding Reneo Pharmaceuticals's shares, representing a decrease of -54.55% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 14,704,650 | -46.26% |
| 31 Mar, 24 | 27,363,476 | 8.32% |
| 31 Dec, 23 | 25,262,300 | -7.60% |
| 30 Sep, 23 | 27,339,727 | 4.28% |
| 30 Jun, 23 | 26,216,540 | 53.62% |
| 31 Mar, 23 | 17,065,991 | 3.66% |
| 31 Dec, 22 | 16,462,908 | 0.16% |
| 30 Sep, 22 | 16,437,081 | 0.48% |
| 30 Jun, 22 | 16,359,148 | -5.28% |
| 31 Mar, 22 | 17,271,132 | -0.82% |
| 31 Dec, 21 | 17,413,762 | -5.20% |
| 30 Sep, 21 | 18,368,080 | 0.37% |
| 30 Jun, 21 | 18,300,692 | - |
Reneo Pharmaceuticals (RPHM) has 14.70M shares outstanding as of 30 Jun 24, down -46.26% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 44.00% | 0.67% |
| 31 Mar, 24 | 80.94% | 1.45% |
| 31 Dec, 23 | 74.72% | 0.91% |
| 30 Sep, 23 | 90.48% | 0.83% |
| 30 Jun, 23 | 104.71% | 2.25% |
| 31 Mar, 23 | 68.16% | 1.51% |
| 31 Dec, 22 | 67.21% | 1.49% |
| 30 Sep, 22 | 67.10% | 1.50% |
| 30 Jun, 22 | 66.87% | 1.34% |
| 31 Mar, 22 | 70.61% | 0.77% |
| 31 Dec, 21 | 95.98% | 1.69% |
| 30 Sep, 21 | 75.29% | 1.03% |
| 30 Jun, 21 | 85.66% | - |
As of 30 Jun 24, Reneo Pharmaceuticals is held by 44.00% institutional shareholders, representing a 0.67% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -50.00% |
| 31 Mar, 24 | 28 | -40.43% |
| 31 Dec, 23 | 47 | 46.88% |
| 30 Sep, 23 | 32 | -17.95% |
| 30 Jun, 23 | 39 | 143.75% |
| 31 Mar, 23 | 16 | 77.78% |
| 31 Dec, 22 | 9 | -18.18% |
| 30 Sep, 22 | 11 | - |
| 30 Jun, 22 | 11 | -8.33% |
| 31 Mar, 22 | 12 | -36.84% |
| 31 Dec, 21 | 19 | 35.71% |
| 30 Sep, 21 | 14 | -62.16% |
| 30 Jun, 21 | 37 | - |
14 institutional shareholders have increased their position in RPHM stock as of 30 Jun 24 compared to 28 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -47.37% |
| 31 Mar, 24 | 19 | 18.75% |
| 31 Dec, 23 | 16 | 23.08% |
| 30 Sep, 23 | 13 | 160.00% |
| 30 Jun, 23 | 5 | -28.57% |
| 31 Mar, 23 | 7 | -36.36% |
| 31 Dec, 22 | 11 | 37.50% |
| 30 Sep, 22 | 8 | -20.00% |
| 30 Jun, 22 | 10 | -23.08% |
| 31 Mar, 22 | 13 | 160.00% |
| 31 Dec, 21 | 5 | -54.55% |
| 30 Sep, 21 | 11 | - |
| 30 Jun, 21 | - | - |
10 institutional shareholders have reduced their position in RPHM stock as of 30 Jun 24 compared to 19 in the previous quarter (a -47.37% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 30 | -54.55% | 14,704,650 | -46.26% | 44.00% | 0.67% | 14 | -50.00% | 10 | -47.37% |
| 31 Mar, 24 | 66 | -15.38% | 27,363,476 | 8.32% | 80.94% | 1.45% | 28 | -40.43% | 19 | 18.75% |
| 31 Dec, 23 | 78 | 32.20% | 25,262,300 | -7.60% | 74.72% | 0.91% | 47 | 46.88% | 16 | 23.08% |
| 30 Sep, 23 | 59 | 15.69% | 27,339,727 | 4.28% | 90.48% | 0.83% | 32 | -17.95% | 13 | 160.00% |
| 30 Jun, 23 | 51 | 50.00% | 26,216,540 | 53.62% | 104.71% | 2.25% | 39 | 143.75% | 5 | -28.57% |
| 31 Mar, 23 | 34 | 9.68% | 17,065,991 | 3.66% | 68.16% | 1.51% | 16 | 77.78% | 7 | -36.36% |
| 31 Dec, 22 | 31 | - | 16,462,908 | 0.16% | 67.21% | 1.49% | 9 | -18.18% | 11 | 37.50% |
| 30 Sep, 22 | 31 | 6.90% | 16,437,081 | 0.48% | 67.10% | 1.50% | 11 | - | 8 | -20.00% |
| 30 Jun, 22 | 29 | -27.50% | 16,359,148 | -5.28% | 66.87% | 1.34% | 11 | -8.33% | 10 | -23.08% |
| 31 Mar, 22 | 40 | 2.56% | 17,271,132 | -0.82% | 70.61% | 0.77% | 12 | -36.84% | 13 | 160.00% |
| 31 Dec, 21 | 39 | 2.63% | 17,413,762 | -5.20% | 95.98% | 1.69% | 19 | 35.71% | 5 | -54.55% |
| 30 Sep, 21 | 38 | 2.70% | 18,368,080 | 0.37% | 75.29% | 1.03% | 14 | -62.16% | 11 | - |
| 30 Jun, 21 | 37 | - | 18,300,692 | - | 85.66% | - | 37 | - | - | - |
Reneo Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Reneo Pharmaceuticals's stock was made by Leonard Braden Michael on May 16 2024, selling - shares at - per share (valued at -). The last insider buy of RPHM was made by Leonard Braden Michael on Aug 14 2024, buying 100,487 shares at $1.41 per share (worth $142.01K).
Reneo Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 2 | 1 | 200.00% |
| Q3 2023 | 1 | 3 | 33.33% |
| Q2 2023 | 8 | 2 | 400.00% |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 5 | 3 | 166.67% |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 2 | 4 | 50.00% |
| Q4 2021 | 10 | 1 | 1000.00% |
| Q3 2021 | 5 | 2 | 250.00% |
| Q2 2021 | 30 | 13 | 230.77% |
| Q1 2021 | - | 2 | - |
| Q4 2020 | - | 5 | - |
| Q2 2019 | - | 4 | - |
| Q1 2019 | - | 1 | - |
| Q1 2018 | - | 3 | - |
| Q3 2017 | - | 1 | - |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Reneo Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 2 | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 1 | 1 | 100.00% |
| Q4 2022 | - | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 4 | 1 | 400.00% |
| Q2 2021 | 14 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q1 2018 | - | - | - |
| Q3 2017 | - | - | - |
As of Q3 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Reneo Pharmaceuticals's stocks.
Reneo Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| DNA | Ginkgo Bioworks Holdings, Inc. |
| CNSP | CNS Pharmaceuticals, Inc. |
| ADPT | Adaptive Biotechnologies Corporation |
| CGEM | Cullinan Oncology, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| PRME | Prime Medicine, Inc. |
| LEGN | Legend Biotech Corporation |
| AVRO | AVROBIO, Inc. |
| KRON | Kronos Bio, Inc. |
| VIR | Vir Biotechnology, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| IMMX | Immix Biopharma, Inc. |
| SMMT | Summit Therapeutics Inc. |
| RPRX | Royalty Pharma plc |
| HOWL | Werewolf Therapeutics, Inc. |
| OCEA | Ocean Biomedical, Inc. |
| NKTX | Nkarta, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| CELC | Celcuity Inc. |
RPHM Ownership FAQ
Who Owns Reneo Pharmaceuticals?
Reneo Pharmaceuticals is owned by institutional shareholders (44.00%), insiders (5.19%), and public (50.81%). The largest institutional shareholder of Reneo Pharmaceuticals is NEA MANAGEMENT COMPANY, LLC (14.32% of total shares) and the top mutual fund owner is FRANKLIN STRATEGIC SERIES (0.06% of total shares).
Who are the major institutional shareholders of Reneo Pharmaceuticals?
Reneo Pharmaceuticals's major institutional shareholders are NEA MANAGEMENT COMPANY, LLC, TANG CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, CARLYLE GROUP INC., and BML CAPITAL MANAGEMENT, LLC. The top five shareholders own together 48.08% of the company's share outstanding.
How many Reneo Pharmaceuticals shareholders are there?
As of Jun 2024, there are 30 institutional shareholders of Reneo Pharmaceuticals.
What percentage of Reneo Pharmaceuticals is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC owns 4.79M shares of Reneo Pharmaceuticals, representing 14.32% of the company's total shares outstanding, valued at $7.23M (as of Jun 2024).
What percentage of Reneo Pharmaceuticals is owned by TANG CAPITAL MANAGEMENT LLC?
As of Jun 2024, TANG CAPITAL MANAGEMENT LLC holds 3M shares of Reneo Pharmaceuticals (RPHM), compromising 8.97% of the company, valued at $4.52M.
What percentage of Reneo Pharmaceuticals is owned by HIGHBRIDGE CAPITAL MANAGEMENT LLC?
HIGHBRIDGE CAPITAL MANAGEMENT LLC is the third largest holder of Reneo Pharmaceuticals. The company owns 2.92M of the company's shares outstanding (worth $4.4M).